Back
Speaker illustration

Doctor Arman Qamar

Brigham and Women's Hospital, Boston (United States of America)

Presentations

Efficacy and safety of edoxaban vs. warfarin in patients with atrial fibrillation and hepatic disease: Insights from the ENGAGE AF-TIMI 48 trial

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources